Kallmann syndrome (KS) is characterized by two major physiological deficits, anosmia and hypogonadism. These deficits are the likely result of a neuronal targeting defect of the olfactory axons and a migration failure of GnRH-secreting neurons to the hypothalamus. To date, five genes associated with this syndrome have been identified, namely, KAL1, FGFR1, FGF8, PROKR2, and PROK2; though these only account for approximately 30% of all KS cases. The first gene identified was KAL1, which encodes a secreted cell adhesion protein named anosmin-1 and is responsible for the X-linked form of the KS. Misexpressing the homolog of anosmin-1/KAL1 in Caenorhabditis elegans causes a highly penetrant axonal branching phenotype. In a small pilot modifier screen of the
kal-1 gain of function phenotype we have previously isolated a total of seven alleles including mutations in the Heparan sulfate (HS) 6O-sulfotransferase, the HS epimerase and the PAPS (phosphoadenosyl-phosphosulfate) transporter 1. We have expanded this screen to identify more loci that genetically interact with
kal-1. To date, we have isolated an additional 19 candidate mutations including 18 suppressor mutants and one enhancer mutation of the branching phenotype. We will report on the progress of characterizing the newly identified mutations. Characterization of the identified genes should afford us to gain a deeper understanding of how
kal-1 acts during the development of the nervous system and the role of the extracellular matrix in this process. Additionally, these genes may represent candidate genes to cause Kallmann Syndrome in humans.